Colorado
|
|
84-1116894
|
(State
or other jurisdiction of
|
|
(I.R.S.
Employer
|
incorporation
or organization)
|
|
Identification
No.)
|
12600
West Colfax, Suite C-420, Lakewood, Colorado
|
80215
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Large
accelerated filer o
|
Accelerated filer o
|
|
|
Non-accelerated filer o
|
Smaller reporting company x
|
||
(Do not check if a smaller
|
|||
reporting company)
|
PAGE NO.
|
||||
Part
I – Financial Information
|
||||
Item
1.
|
Unaudited
Condensed Consolidated Financial Statements
|
|||
a.
|
Unaudited
Condensed Consolidated Balance Sheets as of September 30, 2008
and
December 31, 2007
|
3
|
||
b.
|
Unaudited
Condensed Consolidated Statements of Operations for the nine
months ended
September 30, 2008 and 2007
|
5
|
||
c.
|
Unaudited
Condensed Consolidated Statements of Income for the three months
ended
September 30, 2008 and 2007
|
6
|
||
d.
|
Unaudited
Condensed Consolidated Statement of Stockholders’ Equity for the nine
months ended September 30, 2008
|
7
|
||
e.
|
Unaudited
Condensed Consolidated Statements of Cash Flows for the nine months
ended
September 30, 2008 and 2007
|
8
|
||
f.
|
Notes
to Unaudited Condensed Consolidated Financial Statements
|
10
|
||
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
operations
|
24
|
||
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
32
|
||
Item
4.
|
Controls
and Procedures
|
32
|
||
Part
II – Other Information
|
33
|
|||
Item 1.
|
Legal
Proceedings
|
33
|
||
Item 1A
|
Risk
Factors
|
33
|
||
Item 2.
|
Unregistered
sales of Equity Securities and Use of Proceeds
|
33
|
||
Item 3.
|
Defaults
Upon Senior Securities
|
33
|
||
Item 4.
|
Submission
of Matters to a Vote of Security Holders
|
33
|
||
Item 5.
|
Other
Information
|
34
|
||
Item 6.
|
Exhibits
and Reports on Form 8-K
|
35
|
||
Signatures
|
36
|
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
6,519
|
$
|
6,748
|
|||
Marketable
Securities
|
517
|
—
|
|||||
Accounts
receivable-trade, net
|
4,264
|
3,029
|
|||||
Accrued
revenues, net
|
1,757
|
822
|
|||||
Prepaid
expenses and other assets
|
1,025
|
316
|
|||||
Deferred
tax asset
|
1,871
|
740
|
|||||
Total
current assets
|
15,953
|
11,655
|
|||||
Equipment,
furniture and fixtures, net
|
1,243
|
342
|
|||||
Intangibles
|
1,707
|
—
|
|||||
Goodwill
|
5,692
|
—
|
|||||
Software,
net
|
4,226
|
173
|
|||||
Total
assets
|
$
|
28,821
|
$
|
12,170
|
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
(Unaudited)
|
|||||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
|||||||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable
|
$
|
1,461
|
$
|
322
|
|||
Accrued
expenses and other current liabilities
|
4,703
|
3,377
|
|||||
Deferred
revenue
|
5,031
|
4,475
|
|||||
Litigation
accrual
|
667
|
—
|
|||||
Obligation
to Inlog’s sellers, current
|
1,162
|
—
|
|||||
Capital
lease obligation, notes payable, and lines of credit, current
portions
|
877
|
36
|
|||||
Total
current liabilities
|
13,901
|
8,210
|
|||||
Litigation
accrual
|
1,004
|
1,004
|
|||||
Obligation
to Inlog’s sellers, less current portion
|
1,086
|
—
|
|||||
Capital
lease obligation, notes payable, and lines of credit, less current
portion
|
7,066
|
26
|
|||||
Total
liabilities
|
23,057
|
9,240
|
|||||
COMMITMENT
AND CONTINGENCIES
|
|||||||
STOCKHOLDERS'
EQUITY:
|
|||||||
Convertible
Preferred Stock Series A, $.01 par value:
|
|||||||
Authorized
shares – 100; 7 and 8 outstanding at September 30, 2008 and December
31, 2007, respectively
|
7,100
|
7,735
|
|||||
Convertible
Preferred Stock Series BB, $.01 par value:
|
|||||||
Authorized
shares – 675; none outstanding
|
—
|
||||||
Preferred
stock, $.01 par value: Authorized shares - 5,725; None
issued or outstanding
|
—
|
||||||
Common
stock, $.01 par value: Authorized shares – 90,000;
Issued and outstanding shares – 32,356 and 26,674 at
September 30, 2008 and December 31, 2007, respectively
|
324
|
267
|
|||||
Additional
paid-in capital
|
58,715
|
54,288
|
|||||
Accumulated
deficit
|
(59,076
|
)
|
(59,360
|
)
|
|||
Comprehensive
income
|
(328
|
)
|
—
|
||||
Currency
translation adjustment
|
(971
|
)
|
—
|
||||
Total
stockholders’ equity
|
5,764
|
2,930
|
|||||
Total
liabilities and stockholders' equity
|
$
|
28,821
|
$
|
12,170
|
Three
months ended
|
|||||||
September
30,
|
|||||||
2008
|
2007
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
Revenues
|
$
|
6,940
|
$
|
4,094
|
|||
Cost
of revenues
|
2,759
|
1,172
|
|||||
Gross
profit
|
4,181
|
2,922
|
|||||
OPERATING
EXPENSES:
|
|||||||
General
and administrative
|
1,682
|
875
|
|||||
Sales
and marketing
|
1,055
|
670
|
|||||
Research
and development
|
1,214
|
783
|
|||||
Depreciation
and software amortization
|
348
|
47
|
|||||
Total
operating expenses
|
4,299
|
2,375
|
|||||
Income
(loss) from operations
|
(118
|
)
|
547
|
||||
OTHER
INCOME (EXPENSE):
|
|||||||
Interest
income
|
27
|
42
|
|||||
Interest
expense
|
(191
|
)
|
(3
|
)
|
|||
Total
other income (expense)
|
(164
|
)
|
39
|
||||
Income
(loss) before provision for income tax
|
(282
|
)
|
586
|
||||
Income
tax (expense) benefit
|
54
|
(34
|
)
|
||||
Net
(loss) income
|
$
|
(228
|
)
|
$
|
552
|
||
Basic
and Diluted net income per common share
|
|||||||
Basic
|
$
|
(0.01
|
)
|
$
|
0.02
|
||
Diluted
|
$
|
(0.01
|
)
|
$
|
0.01
|
||
Weighted
average number of common shares outstanding
|
|||||||
Basic
|
30,754
|
25,600
|
|||||
Diluted
|
30,754
|
44,469
|
|||||
Net
(loss) income
|
(228
|
)
|
552
|
||||
Other
comprehensive loss
|
(1,299
|
)
|
—
|
||||
Comprehensive
loss
|
(1,527
|
)
|
552
|
Nine
months ended
September
30,
|
|||||||
2008
|
2007
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
Revenues
|
$
|
16,378
|
$
|
11,782
|
|||
Cost
of revenues
|
6,177
|
3,566
|
|||||
Gross
profit
|
10,201
|
8,216
|
|||||
OPERATING
EXPENSES:
|
|||||||
General
and administrative
|
3,747
|
2,415
|
|||||
Sales
and marketing
|
2,430
|
1,943
|
|||||
Research
and development
|
2,722
|
2,541
|
|||||
Depreciation
and software amortization
|
462
|
128
|
|||||
Total
operating expenses
|
9,361
|
7,027
|
|||||
Income
from operations
|
840
|
1,189
|
|||||
OTHER
INCOME (EXPENSE):
|
|||||||
Interest
income
|
86
|
167
|
|||||
Interest
expense
|
(212
|
)
|
(9
|
)
|
|||
Total
other income
|
(126
|
)
|
158
|
||||
Income
before provision for income tax
|
714
|
1,347
|
|||||
Provision
for income tax expense
|
(430
|
)
|
(49
|
)
|
|||
|
|||||||
Net
income
|
284
|
1,298
|
|||||
Basic
and diluted net income per common share
|
|||||||
Basic
|
$
|
0.01
|
$
|
0.05
|
|||
Diluted
|
$
|
0.01
|
$
|
0.03
|
|||
Weighted
average number of common shares outstanding:
|
|||||||
Basic
|
28,546
|
24,035
|
|||||
Diluted
|
46,898
|
41,052
|
|||||
Net
income
|
284
|
1,298
|
|||||
Other
comprehensive loss
|
(1,299
|
)
|
—
|
||||
Comprehensive
loss
|
$
|
(1,015
|
)
|
$
|
1,298
|
Accumulated
|
|||||||||||||||||||||||||
Other
|
|||||||||||||||||||||||||
Preferred
Stock
|
Common
Stock
|
Additional
|
Accumulated
|
Comprehensive
|
|||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Paid-in Capital
|
Deficit
|
Income
(loss)
|
Total
|
||||||||||||||||||
Balances,
December 31, 2007
|
8
|
$
|
7,735
|
26,674
|
$
|
267
|
$
|
54,288
|
$
|
(59,360
|
)
|
—
|
$
|
2,930
|
|||||||||||
Expense
associated with issuance of options for services to employees or
consultants, (unaudited)
|
—
|
—
|
—
|
—
|
253
|
—
|
—
|
253
|
|||||||||||||||||
Exercise
of options for cash (unaudited)
|
—
|
—
|
606
|
6
|
452
|
—
|
—
|
458
|
|||||||||||||||||
Cashless
exercise of options (unaudited)
|
—
|
—
|
545
|
5
|
(5
|
)
|
—
|
—
|
—
|
||||||||||||||||
Issuance
of common stock in connection with the Inlog acquisition
(unaudited)
|
—
|
—
|
451
|
5
|
563
|
—
|
—
|
568
|
|||||||||||||||||
Issuance
of common stock in connection with the eDonor acquisition
(unaudited)
|
—
|
—
|
1,180
|
12
|
1,488
|
—
|
—
|
1,500
|
|||||||||||||||||
Cashless
exercise of warrant
|
|||||||||||||||||||||||||
(unaudited)
|
—
|
—
|
695
|
7
|
(7
|
)
|
—
|
—
|
—
|
||||||||||||||||
Exercise
of warrants for cash (unaudited)
|
—
|
—
|
1,308
|
13
|
948
|
—
|
—
|
961
|
|||||||||||||||||
Issuance
of warrants in connection with financing (unaudited)
|
—
|
—
|
—
|
—
|
81
|
—
|
—
|
81
|
|||||||||||||||||
Vesting
of restricted stock
|
|||||||||||||||||||||||||
(unaudited)
|
—
|
—
|
15
|
—
|
28
|
—
|
—
|
28
|
|||||||||||||||||
Conversion
of Series A Preferred Stock to common shares (unaudited)
|
(1
|
)
|
(635
|
)
|
882
|
9
|
626
|
—
|
—
|
—
|
|||||||||||||||
Other
comprehensive income -Net unrealized gains (losses)
(unaudited)
|
—
|
—
|
—
|
—
|
—
|
—
|
(328
|
)
|
(328
|
)
|
|||||||||||||||
-Translation
adjustments (unaudited)
|
—
|
—
|
—
|
—
|
—
|
—
|
(971
|
)
|
(971
|
)
|
|||||||||||||||
Net
income (unaudited)
|
—
|
—
|
—
|
—
|
—
|
284
|
—
|
320
|
|||||||||||||||||
7
|
$
|
7,100
|
32,356
|
$
|
324
|
$
|
58,715
|
$
|
(59,076
|
)
|
$
|
(1,299
|
)
|
$
|
5,764
|
Nine
months ended
|
|||||||
September
30,
|
|||||||
2008
|
2007
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
income
|
$
|
284
|
$
|
1,298
|
|||
Adjustments
to reconcile net income to net cash provided by operating
activities:
|
|||||||
Depreciation
and amortization
|
462
|
128
|
|||||
Financing
costs
|
39
|
—
|
|||||
Bad
debt expense
|
47
|
83
|
|||||
Common
stock, options and warrants issued
|
|||||||
for
services and other, net
|
281
|
174
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable-trade, net
|
512
|
1,089
|
|||||
Accrued
revenues, net
|
1,094
|
(304
|
)
|
||||
Prepaid
expenses and other assets
|
(97
|
)
|
41
|
||||
Escrow
deposit
|
—
|
1,004
|
|||||
Deferred
tax asset
|
328
|
—
|
|||||
Accounts
payable
|
631
|
219
|
|||||
Accrued
expenses and other current liabilities
|
(1,504
|
)
|
127
|
||||
Deferred
revenue
|
(963
|
)
|
(488
|
)
|
|||
Net
cash provided by operating activities
|
1,114
|
3,371
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Purchases
of equipment, furniture and fixtures
|
(267
|
)
|
(224
|
)
|
|||
Capitalized
software development
|
(148
|
)
|
—
|
||||
Acquisitions,
net of cash acquired
|
(9,464
|
)
|
—
|
||||
Net
cash used in investing activities
|
(9,879
|
)
|
(224
|
)
|
Nine
months ended
|
|||||||
September
30, 2008
|
|||||||
2008
|
2007
|
||||||
(Unaudited)
|
(Unaudited)
|
||||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Borrowing,
notes payable and principal payments on debt and capital lease
obligations, net of financing costs
|
7,231
|
(24
|
)
|
||||
Exercise
of options and warrants for cash
|
1,421
|
68
|
|||||
Net
cash provided by financing activities
|
8,652
|
44
|
|||||
Effect
of exchange rate changes on cash
|
(116
|
)
|
—
|
||||
NET
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(229
|
)
|
3,191
|
||||
CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
|
6,748
|
2,554
|
|||||
CASH
AND CASH EQUIVALENTS AT END OF PERIOD
|
$
|
6,519
|
$
|
5,745
|
|||
SUPPLEMENTAL
DISCLOSURES
|
|||||||
Non-cash
financing activities:
|
|||||||
Conversion
of Series A Preferred Stock to common shares
|
$
|
635
|
$
|
2,015
|
|||
Fair
value of common stock issued in connection with Inlog
acquisition
|
568
|
—
|
|||||
Fair
value of obligation to sellers related to Inlog
acquisition
|
2,248
|
—
|
|||||
Fair
value of common stock issued in connection with eDonor
acquisition
|
1,500
|
—
|
Level
1
|
Level
2
|
Total
|
||||||||
Assets
|
|
|
|
|||||||
Cash
equivalents
|
$
|
919
|
—
|
$
|
919
|
|||||
Short-term
investments
|
286
|
—
|
286
|
|||||||
Marketable
equity securities
|
231
|
—
|
231
|
|||||||
Total
|
$
|
1,436
|
—
|
$
|
1,436
|
In
($000s)
|
||||
Consideration
paid on the Acquisition Date
|
||||
Payment
of cash at the Acquisition Date
|
$
|
6,891
|
||
Value
of common stock issued at the Acquisition Date
|
568
|
|||
Future
consideration to be paid
|
||||
Payment
of cash one year from the Acquisition Date (1)
|
629
|
|||
Cash
payment to be made two years after the Acquisition Date
(1)
|
629
|
|||
Common
stock to be issued one year after the Acquisition Date (2)
|
651
|
|||
Common
stock to be issued two years after the Acquisition Date
(2)
|
651
|
|||
Total
non-contingent consideration associated with the acquisition,
undiscounted
|
$
|
10,019
|
||
Acquisition-related
costs (estimated) (3)
|
1,067
|
|||
Discount
on future consideration
|
(254
|
)
|
||
|
||||
Total
fixed consideration
|
$
|
10,832
|
Value of
Common Shares
in ($000)
|
Number of Common
Shares Issued or
Contingently Issuable
in (000s)
|
||||||
Common
shares issued at Acquisition Date
|
$
|
568
|
451
|
||||
Common
shares to be issued one year after the Acquisition Date
(2)
|
651
|
517
|
|||||
Common
shares to be issued two years after the Acquisition Date
(2)
|
651
|
517
|
|||||
$
|
1,870
|
1,485
|
(in $000s)
|
||||
Cash
and marketable securities
|
$
|
2,783
|
||
Trade
receivables and unbilled receivable, net
|
3,809
|
|||
Intangible
assets
|
860
|
|||
Goodwill
|
3,660
|
|||
Software
|
2,861
|
|||
Equipment,
furniture, fixtures, leasehold improvement
|
853
|
|||
Deferred
tax assets, net
|
1,345
|
|||
Other
assets
|
714
|
|||
Accounts
payable and other liabilities
|
(3,840
|
)
|
||
Deferred
revenues
|
(1,393
|
)
|
||
Debt
|
(820
|
)
|
||
Total
preliminary purchase price
|
$
|
10,832
|
Preliminary
Fair Value
|
Accumulated
Amortization
|
Currency
Translation
Adjustment
|
Net Book
Value
|
Estimated
Useful Life
|
||||||||||||
Non-compete
agreements, customer relationships, and other
|
$
|
860
|
(33
|
)
|
(78
|
)
|
$
|
749
|
5-10 years
|
In
($000s)
|
||||
Cash
consideration
|
$
|
3,500
|
||
Common
stock issued (1.18 million shares at $1.27 per share)
|
1,500
|
|||
Total
cash and stock consideration
|
$
|
5,000
|
||
Estimated
acquisition-related costs
|
25
|
|||
Total
purchase price
|
$
|
5,025
|
(in $000s)
|
||||
Cash
|
$
|
201
|
||
Unbilled
receivables, net
|
14
|
|||
Intangible
assets
|
970
|
|||
Software
|
1,510
|
|||
Equipment,
furniture, fixtures, leasehold improvement
|
70
|
|||
Goodwill
|
2,360
|
|||
Other
assets
|
27
|
|||
Deferred
revenues
|
(127
|
)
|
||
|
||||
Total
preliminary purchase price
|
$
|
5,025
|
Preliminary
Fair
Value
|
Accumulated
Amortization
|
Net
Book
Value
|
Estimated
Useful
Life
|
||||||||||
Trade
names and customer relationships
|
$
|
970
|
(12
|
)
|
$
|
958
|
Trade name, indefinite, customer relationships, 9 years |
|
Three Months Ended
September
30,
|
Nine Months Ended
September
30,
|
|||||||||||
(in
$000s, except per share data)
|
2008
|
2007
|
2008
|
2007
|
|||||||||
Total
revenues
|
$
|
7,129
|
$
|
7,329
|
$
|
24,272
|
$
|
23,535
|
|||||
Net
(loss) income
|
$
|
(238
|
)
|
$
|
926
|
$
|
235
|
$
|
1,448
|
||||
Basic
net (loss) income per share
|
$
|
(0.01
|
)
|
$
|
0.03
|
$
|
0.01
|
$
|
0.06
|
||||
Diluted
net (loss) income per share
|
$
|
(0.01
|
)
|
$
|
0.02
|
$
|
0.00
|
$
|
0.03
|
|
Shares
|
Weighted
Average
Exercise Price
|
Weighted
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
|||||||||
Number
of shares under option:
|
|
|
|
|
|||||||||
Outstanding
at January 1, 2008
|
10,823,602
|
$
|
0.82
|
||||||||||
Granted
|
—
|
—
|
|
|
|||||||||
Exercised
|
(1,150,651
|
)
|
0.85
|
||||||||||
Canceled
or expired
|
(1,023,915
|
)
|
0.78
|
|
|
||||||||
Outstanding
at September 30, 2008
|
8,649,036
|
$
|
0.83
|
4.3
|
$
|
7,157,104
|
|||||||
Exercisable
at September 30, 2008
|
7,722,180
|
$
|
0.
80
|
4.0
|
$
|
6,163,302
|
Shares
|
Weighted
Average
Fair
Value
|
||||||
Nonvested
at January 1, 2008
|
1,117,703
|
$
|
0.93
|
||||
Granted
|
—
|
—
|
|||||
Canceled
or expired
|
(5,880
|
)
|
1.15
|
||||
Vested
|
(184,967
|
)
|
0.74
|
||||
Nonvested
at September 30, 2008
|
926,856
|
$
|
0.84
|
|
Nine Months Ended September 30,
|
||||||
|
2008
|
2007
|
|||||
Weighted
average fair value at date of grant for options granted during
the
period
|
$
|
—
|
$
|
119,000
|
|||
Risk-free
interest rates
|
—
|
4.42
|
%
|
||||
Expected
stock price volatility
|
—
|
363
|
%
|
||||
Expected
dividend yield
|
—
|
0
|
|
Shares
|
Weighted
Average Grant
Date Fair Value
|
|||||
|
|
||||||
Nonvested
at January 1, 2008
|
—
|
$
|
—
|
||||
Granted
|
132,667
|
1.27
|
|||||
Vested
|
(15,168
|
)
|
1.27
|
||||
Nonvested
at September 30, 2008
|
117,499
|
$
|
1.27
|
Nine
Months Ended September 30,
|
|||||||
2008
|
2007
|
||||||
Weighted
average number of shares used in the basic
|
|
|
|||||
Earnings
per share computation
|
28,546
|
24,035
|
|||||
Effect
of dilutive securities:
|
|
||||||
Common
stock options
|
3,010
|
1,744
|
|||||
Common
stock warrants
|
4,563
|
2,235
|
|||||
Restricted
stock
|
22
|
—
|
|||||
Preferred
stock convertible securities
|
10,419
|
13,038
|
|||||
Contingently
issuable shares associated
|
|||||||
with
Inlog acquisition
|
338
|
—
|
|||||
Dilutive
securities
|
18,352
|
17,017
|
|||||
Adjusted
weighted average number of shares used in diluted earnings per
share
computation
|
46,898
|
41,052
|
•
|
|
Upgrade
their current system with their existing vendor,
or
|
•
|
|
Select
a replacement system from an alternative
vendor.
|
Europe, Middle East
& Africa
|
United States
|
Total
|
||||||||
Three
Months Ended
|
||||||||||
2008*
|
$
|
2,568
|
$
|
4,372
|
$
|
6,940
|
||||
2007
|
-
|
4,094
|
4,094
|
|||||||
Nine
Months Ended
|
||||||||||
2008*
|
$
|
2,742
|
$
|
13,636
|
$
|
16,378
|
||||
2007
|
-
|
11,782
|
11,782
|
2008
|
2007
|
||||||
Maintenance*
|
53.2
|
%
|
42.1
|
%
|
|||
Consulting
services*
|
23.0
|
%
|
24.4
|
%
|
|||
Software
license fees*
|
21.1
|
%
|
31.4
|
%
|
|||
PeopleMed*
|
2.7
|
%
|
2.1
|
%
|
|||
Total
Revenue
|
100
|
%
|
100
|
%
|
2008
|
2007
|
||||||
Maintenance
|
47.3
|
%
|
42.3
|
%
|
|||
Consulting
services
|
27.1
|
%
|
25.5
|
%
|
|||
Software
license fees
|
22.0
|
%
|
29.6
|
%
|
|||
PeopleMed
|
3.6
|
%
|
2.6
|
%
|
|||
Total
Revenue
|
100
|
%
|
100
|
%
|
Exhibit
No.
|
Description
|
|
3.1
|
Bylaws, as amended | |
10.97
|
Executive
Employment Agreement dated November 3, 2008 between the Company and
Karen
Davis
|
31.1
|
Certification
of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002
|
|
31.2
|
Certification
of the Acting Chief Financial Officer pursuant to Section 302 of
the
Sarbanes-Oxley Act of 2002
|
|
32.1
|
Certification
of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
32.2
|
Certification
of Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350,
as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
99.1
|
Press
release issued by Global Med Technologies, Inc. on November 13, 2008
|
Date:
November 13, 2008
|
GLOBAL
MED TECHNOLOGIES, INC.
|
A
Colorado Corporation
|
|
/s/
Michael I. Ruxin, M.D.
|
|
Michael
I. Ruxin, M.D. Chairman of the Board
|
|
and
Chief Executive Officer
|
|
Date:
November 13, 2008
|
/s/
Darren P. Craig
|
Darren
P. Craig, Acting Chief Financial
Officer
|